Enanta製藥（納斯達克股票代碼：ENTA）報告季度每股虧損$(1.36)，相比去年同期每股虧損$(1.33)，下降了2.26%。公司本季度銷售額爲$1461萬，相比去年同期的$1893萬下降了22.84%。

以上內容來自Benzinga Earnings專欄，原文如下：

Enanta Pharma (NASDAQ:ENTA) reported quarterly losses of $(1.36) per share. This is a 2.26 percent decrease over losses of $(1.33) per share from the same period last year. The company reported $14.61 million in sales this quarter. This is a 22.84 percent decrease over sales of $18.93 million the same period last year.